BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Törnquist K, Asghar MY, Srinivasan V, Korhonen L, Lindholm D. Sphingolipids as Modulators of SARS-CoV-2 Infection. Front Cell Dev Biol 2021;9:689854. [PMID: 34222257 DOI: 10.3389/fcell.2021.689854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu T, Jin J, Chen M, Chen Y. The impact of infection with COVID-19 on the respiratory microbiome: A narrative review. Virulence 2022;13:1076-87. [PMID: 35763685 DOI: 10.1080/21505594.2022.2090071] [Reference Citation Analysis]
2 Bakillah A, Hejji FA, Almasaud A, Jami HA, Hawwari A, Qarni AA, Iqbal J, Alharbi NK. Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells. Nutrients 2022;14:3417. [PMID: 36014919 DOI: 10.3390/nu14163417] [Reference Citation Analysis]
3 Mas M, García-vicente JA, Estrada-gelonch A, Pérez-mañá C, Papaseit E, Torrens M, Farré M. Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence. JCM 2022;11:4038. [DOI: 10.3390/jcm11144038] [Reference Citation Analysis]
4 Teodori L, Osimani B, Isidoro C, Ramakrishna S. Mass versus personalized medicine against COVID-19 in the "system sciences" era. Cytometry A 2022. [PMID: 35716116 DOI: 10.1002/cyto.a.24662] [Reference Citation Analysis]
5 Cui GY, Rao BC, Zeng ZH, Wang XM, Ren T, Wang HY, Luo H, Ren HY, Liu C, Ding SY, Tan JJ, Liu ZG, Zou YW, Ren ZG, Yu ZJ. Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up. Mil Med Res 2022;9:32. [PMID: 35715833 DOI: 10.1186/s40779-022-00387-y] [Reference Citation Analysis]
6 Teixeira L, Temerozo JR, Pereira-dutra FS, Ferreira AC, Mattos M, Gonçalves BS, Sacramento CQ, Palhinha L, Cunha-fernandes T, Dias SSG, Soares VC, Barreto EA, Cesar-silva D, Fintelman-rodrigues N, Pão CRR, de Freitas CS, Reis PA, Hottz ED, Bozza FA, Bou-habib DC, Saraiva EM, de Almeida CJG, Viola JPB, Souza TML, Bozza PT. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts. Front Immunol 2022;13:820131. [DOI: 10.3389/fimmu.2022.820131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hashimoto Y, Suzuki T, Hashimoto K. Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry 2022. [PMID: 34997196 DOI: 10.1038/s41380-021-01432-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 20.0] [Reference Citation Analysis]
8 Rauchman SH, Mendelson SG, Rauchman C, Kasselman LJ, Pinkhasov A, Reiss AB. Ongoing Use of SSRIs Does Not Alter Outcome in Hospitalized COVID-19 Patients: A Retrospective Analysis. J Clin Med 2021;11:70. [PMID: 35011811 DOI: 10.3390/jcm11010070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Clelland CL, Ramiah K, Steinberg L, Clelland JD. Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort. BJPsych Open 2021;8:e6. [PMID: 34859759 DOI: 10.1192/bjo.2021.1053] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Vitner EB, Avraham R, Politi B, Melamed S, Israely T. Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology. Life Sci Alliance 2022;5:e202101168. [PMID: 34764206 DOI: 10.26508/lsa.202101168] [Reference Citation Analysis]
11 Avota E, Bodem J, Chithelen J, Mandasari P, Beyersdorf N, Schneider-Schaulies J. The Manifold Roles of Sphingolipids in Viral Infections. Front Physiol 2021;12:715527. [PMID: 34658908 DOI: 10.3389/fphys.2021.715527] [Reference Citation Analysis]
12 Rahman MH, Rana HK, Peng S, Kibria MG, Islam MZ, Mahmud SMH, Moni MA. Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases. Comput Biol Med 2021;138:104859. [PMID: 34601390 DOI: 10.1016/j.compbiomed.2021.104859] [Reference Citation Analysis]
13 Torretta E, Garziano M, Poliseno M, Capitanio D, Biasin M, Santantonio TA, Clerici M, Lo Caputo S, Trabattoni D, Gelfi C. Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature. Int J Mol Sci 2021;22:10198. [PMID: 34638539 DOI: 10.3390/ijms221910198] [Reference Citation Analysis]
14 Loas G, Le Corre P. Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection. Pharmaceuticals (Basel) 2021;14:691. [PMID: 34358117 DOI: 10.3390/ph14070691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]